
|Videos|May 2, 2022
Johnson & Johnson Surgical Vision (JJV) continues innovation through new and elevated technologies
Author(s)Kassi Filkins
Allie Holmes, head of US marketing for Johnson & Johnson Surgical Vision, shares an update on what visioning the company is doing with their new and elevated technologies.
Advertisement
Johnson & Johnson Surgical Vision (JJV) continues it's innovation through new and elevated technologies, including innovations like their TECNIS Eyhance™ IOL, VERITAS™ Vision System and more. Allie Holmes, Head of US Marketing for JJV, talked with Ophthalmology Times® during the ASCRS Annual Meeting this year in D.C.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
Glaucoma innovation: Eight themes to watch in 2026
3
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
4
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
5












































